![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Takeda Pharmaceutical Co Ltd | LSE:0RN3 | London | Ordinary Share | JP3463000004 | TAKEDA PHARMACEUTICAL ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 49.35 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.28T | 144.07B | 91.0438 | 0.54 | 78.09B |
TIDM43CT TIDM0RN3
RNS Number : 6276M
Morgan Stanley
09 January 2019
FORM 8.5 (EPT/NON-RI)
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION (a) Name of exempt principal trader: Morgan Stanley MUFG Securities Co., Ltd. (b) Name of offeror/offeree in relation to whose relevant securities this Takeda Pharmaceutical Company Limited form relates: Use a separate form for each offeror/offeree ----------------------------------------- (c) Name of the party to the offer with which exempt principal trader is Shire plc connected: ----------------------------------------- (d) Date position held/dealing undertaken 08 JANUARY 2019 For an opening position disclosure, state the latest practicable date prior to the disclosure ----------------------------------------- (e) In addition to the company in 1(b) above, is the exempt principal Yes - Shire plc trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state "N/A" ----------------------------------------- 2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security: Ordinary Interests Short positions ---------------- ----------------- Number % Number % ---------- ---- ----------- ---- (1) Relevant securities owned and/or controlled: 4,423,915 0.56 35,544,949 4.53 ---------- ---- ----------- ---- (2) Cash-settled derivatives: 34,686,223 4.42 3,545,959 0.45 ---------- ---- ----------- ---- (3) Stock-settled derivatives (including options) and agreements to purchase/sell: 315,000 0.04 315,000 0.04 ---------- ---- ----------- ---- TOTAL: 39,425,138 5.03 39,405,908 5.02 ---------- ---- ----------- ----
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options) Class of relevant security in N/A relation to which subscription right exists: Details, including nature of N/A the rights concerned and relevant percentages: ---- 3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales Class of Purchases/ Total number Highest price Lowest price relevant sales of securities per unit paid/received per unit paid/received security Ordinary PURCHASES 3,061,136 4,150.3600 3,972.2495 JPY JPY ----------- --------------- ------------------------ ------------------------ Ordinary SALES 3,014,772 4,150.3600 3,972.2495 JPY JPY ----------- --------------- ------------------------ ------------------------ (b) Cash-settled derivative transactions Class of Product description Nature of dealing Number of reference Price per relevant e.g. CFD e.g. opening/closing securities unit security a long/short position, increasing/reducing a long/short position Ordinary CFD 4085.0000 SHORT 14500 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4064.2296 LONG 27000 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4096.2152 SHORT 68300 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4085.0000 LONG 7000 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 3977.1927 SHORT 24900 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4067.0366 LONG 32700 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4046.0000 SHORT 6500 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4061.2015 LONG 39200 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4068.1666 SHORT 1800 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4082.4074 SHORT 5400 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4068.4210 LONG 3800 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4043.0000 LONG 200 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4068.1086 LONG 300 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4068.1086 LONG 4300 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4056.0000 SHORT 300 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4057.8461 SHORT 9100 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4061.5357 LONG 8400 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4037.9166 SHORT 2400 JPY
-------------------- ------------------------ -------------------- ---------- Ordinary CFD 3995.0000 LONG 1200 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4056.1075 LONG 111196 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4010.1029 SHORT 155697 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4064.7501 LONG 65800 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4043.0780 LONG 601408 JPY -------------------- ------------------------ -------------------- ---------- Ordinary CFD 4062.0253 SHORT 703308 JPY -------------------- ------------------------ -------------------- ---------- (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class Product Writing, Number Exercise Type Expiry Option of description purchasing, of securities price e.g. American, date money paid/ relevant e.g. call selling, to which per unit European received security option varying option etc. per unit etc. relates N/A N/A N/A N/A N/A N/A N/A N/A ------------- ------------- --------------- ---------- ---------------- ------- ------------- (ii) Exercise Class of Product description Exercising/ Number of securities Exercise price relevant e.g. call option exercised per unit security against N/A N/A N/A N/A N/A -------------------- ------------ --------------------- --------------- (d) Other dealings (including subscribing for new securities) Class of relevant Nature of dealing Details Price per unit security e.g. subscription, (if applicable) conversion N/A N/A N/A N/A -------------------- -------- ----------------- 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" NONE (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" NONE (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? YES Date of disclosure: 09 JANUARY 2019 Contact name: Craig Horsley ------------------ Telephone number: +44(141) 245 7736 ------------------
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS,
AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1. KEY INFORMATION Full name of person making disclosure: Morgan Stanley MUFG Securities Co., Ltd. Name of offeror/offeree in relation to whose relevant securities the Takeda Pharmaceutical Company Limited disclosure relates: ----------------------------------------- 2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS) Class of Product Written Number of Exercise Type Expiry relevant description or purchased securities price e.g. American, date security e.g. call to which per unit European option option or etc derivative relates Ordinary PUT PURCHASED 125,000 4507.0000 European 13/12/2019 JPY ------------ ------------- ----------- --------- --------------- ---------- Ordinary CALL PURCHASED 125,000 4507.0000 European 13/12/2019 JPY ------------ ------------- ----------- --------- --------------- ---------- Ordinary PUT PURCHASED 60,000 4596.0000 European 14/06/2019 JPY ------------ ------------- ----------- --------- --------------- ---------- Ordinary CALL PURCHASED 60,000 4596.0000 European 14/06/2019 JPY ------------ ------------- ----------- --------- --------------- ---------- Ordinary PUT PURCHASED 65,000 4414.0000 European 14/06/2019 JPY ------------ ------------- ----------- --------- --------------- ---------- Ordinary CALL PURCHASED 65,000 4414.0000 European 14/06/2019 JPY ------------ ------------- ----------- --------- --------------- ---------- Ordinary PUT PURCHASED 65,000 4414.0000 European 13/12/2019 JPY ------------ ------------- ----------- --------- --------------- ---------- Ordinary CALL PURCHASED 65,000 4414.0000 European 13/12/2019 JPY ------------ ------------- ----------- --------- --------------- ---------- 3. AGREEMENTS TO PURCHASE OR SELL ETC. Full details should be given so that the nature of the interest or position can be fully understood:
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be stated.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
FEOEANFNELPNEEF
(END) Dow Jones Newswires
January 09, 2019 04:49 ET (09:49 GMT)
1 Year Takeda Pharmaceutical Chart |
1 Month Takeda Pharmaceutical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions